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1072AB S TRA C T
Objective: Frailty and depression are highly comorbid conditions, but the
casual direction is unclear and has not been explored in low- and middle-
income countries. The aim of this study was to investigate the potential impact
of depression on incident frailty in older people living in Latin America.
Methods: This study was based on a population-based cohort of 12,844 people
aged 65 or older from six Latin American countries (Cuba, Dominican Repub-
lic, Mexico, Venezuela, Puerto Rico, and Peru), part of the 10/66 cohort study.
Two types of frailty measures were used: a modified Fried frailty phenotype and
a multidimensional frailty criterion, which included measures from cognition,
sensory, nutrition, and physical dimensions. Depression was assessed using
EURO-D and International Classification of Diseases, Tenth Revision criteria. A
competing risk model was used to examine the associations between baseline
depression and incidence of frailty in the 3−5 years of follow-up, accounting
for sociodemographic and health factors and the competing event of frailty-free
death. Results: Depression was associated with a 59% increased hazard of
developing frailty using the modified Fried phenotype (subdistribution hazard
ratio [SHR]: 1.59; 95% confidence interval [CI]: 1.40, 1.80) and 19% for multidi-
mensional frailty (SHR: 1.19; 95% CI: 1.06, 1.33) after adjusting for sociodemo-
graphic factors, physical impairments, and dementia. The associations between
depression and the multidimensional frailty criteria were homogenous acrossKey Words:
Depression
older age
epidemiology
frailty
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Am J Geriatr Psychiatry 27:10, October 201all the sites (Higgins I2 = 0%). Conclusion: Depression may play a key role in
the development of frailty. Pathways addressing the association between physi-
cal and mental health in older people need to be further investigated in future
research. (Am J Geriatr Psychiatry 2019; 27:1072−1079)INTRODUCTION
F railty is an age-related biological syndromeresulting in decreased physiological reserve and
increased susceptibility to stressors during the aging
process,1,2 and ultimately in increased disability and
mortality.3,4 A meta-analysis estimated the preva-
lence of frailty to be 11% in community-dwelling
older people, but range was wide across studies
(4%−59%).5 A multicenter cohort study in five Latin
American cities reported relatively high estimates in
both men (21%−35%) and women (30%−48%).6
Similar to frailty, depression is also a highly preva-
lent condition among older adults and has been
linked to an increased risk of developing frailty in
later life.7 Although recent reviews have suggested
bidirectional associations between depression and
frailty in later life,8−11 it is important to investigate
how depression might lead to incident frailty particu-
larly in low- and middle-income countries, where
high prevalence of depression has been reported in
some settings but access to health services are lim-
ited.12 Given the large number of older people in low-
and middle-income countries, population-based lon-
gitudinal studies are needed to quantify the potential
impact of depression on the development of frailty.
This may lead to the identification of a high-risk
group of individuals who are likely to become frail,
potentially leading to a reduction in burden associ-
ated with both depression and frailty.
Based on the pooled estimates of four longitudinal
studies from the United States and Germany, older
people with depression had four-fold increased odds
of incident frailty, yet the reported heterogeneity of
this meta-analysis was high.8 This might be related to
variation in research methods such as different meas-
ures for depression and frailty. In addition to the clas-
sic Fried criteria, which focuses on five clinical
markers related to declines in physical functioning,13
the multidimensional nature of frailty has been
widely recognized in recent years,14 and several
assessment methods have been developed to9incorporate different dimensions of physical and
mental health indicators.2,13−16 However, few studies
have included different frailty definitions and exam-
ined their effects on the association between depres-
sion and frailty. If the association varied across
different frailty definitions, this might clarify possible
pathways between depression and frailty.
Using a population-based cohort of older people liv-
ing in six Latin American countries, the aim of this
study was to investigate the potential association
between depression and incident frailty in later life.
Moreover, we explored whether the associations main-
tain when a different definition of frailty is considered.METHODS
Sample
The 10/66 Dementia Research Group carried out
surveys of older people aged 65 and over living in 11
catchment areas across eight low- and middle-income
countries (China, Cuba, Dominican Republic, India,
Mexico, Peru, Puerto Rico, and Venezuela). One urban
and one rural site were present in China, Mexico, and
Peru, whereas the other countries only included an
urban site. The catchment area boundaries were well-
defined, and areas with high-income earners were
avoided. The baseline surveys took place between
2003 and 2005 for all sites, with the exception of Puerto
Rico, in which data were collected from 2007. A full
follow-up was carried out 3−5 years after the baseline,
and date of death of those deceased were also
recorded. Informed consent was obtained from all par-
ticipants and verbal consent was used when partici-
pants were illiterate. The study was approved by local
ethical committees and by the King’s College London
research ethics committee. Full details of the protocol
and the cohort are available elsewhere.17,18
This study only focused on a subset of the full 10/66
dataset (N = 15,901), using 12,844 participants from the
six Latin American countries. The Indian sites were
excluded due to incomplete follow-up data. Compared1073
People From Six Latin American Countrieswith Latin American countries, the prevalence of
depression was found to be markedly low in the Chi-
nese sites12 and there was lack of statistical power to
investigate its association with incident frailty.Measurement
Two types of frailty definitions were used in this
analysis. The original Fried frailty phenotype includes
five indicators: exhaustion, weight loss, weak grip
strength, slow walking speed, and low energy expen-
diture. The 10/66 cohort study assessed only four
of the five indicators and did not include measures
of hand grip strength.19,20 Self-reported measures of
exhaustion, weight loss (≥10 lb in the last 3 months),
and low energy expenditure (physically inactive)
were included in the interviews. Walking speed was
assessed using a time walking test (5 meters at usual
speed, turn and return to the starting point) and the
slowest quintile by sex and height stratum in each
catchment area was considered to have a slow walk-
ing speed. Participants were defined as frail if they
had two or more of the four frailty indicators, as done
in previous studies.19,20 To align with the literature,2
a cutoff of three or four frailty indicators was also
applied, yet very few people belonged to this cate-
gory (Supplementary Table S1).
The multidimensional frailty approach was devel-
oped in the Alameda County study21 and previously
used by our group.19,20 It includes 16 self-reported
items that form four broad domains of functioning
(cognitive, nutrition, physical, and sensory). The cogni-
tive functioning domain included attention difficulties
and memory. The nutrition domain included unex-
plained weight loss and loss of appetite. The physical
functioning domain included items measuring balance
loss, dizziness, and weakness in limbs. Finally, the sen-
sory functioning domain included hearing and vision
difficulties. If difficulties in two or more domains were
present, participants were considered frail.
Considering that International Classification of Dis-
eases, Tenth Revision (ICD-10) criteria were not specifi-
cally developed for older adults and might under-
detect depression in later life, depression in this study
was determined using both ICD-10 criteria, which
was generated using specific Geriatric Mental State
Examination (GMS) algorithms,12,22 and the EURO-D
scale.23,24 The EURO-D scale, which was developed
to compare symptoms of late-life depression across107411 European countries, has 12 items including
depressed mood, pessimism, wishing death, guilt,
sleep, interest, irritability, appetite, fatigue, concentra-
tion, enjoyment, and tearfulness. Each item has a
score of 0 (symptom not present) or 1 (symptom pres-
ent), with a total score range between 0 and 12. Par-
ticipants who met the ICD-10 depression criteria or
had a EURO-D score of 4 or 5 were considered to
have depression. Procedures to select the optimal cut-
off of 4 or 5 on the EURO-D scale have been reported
in the EURO-D validation articles, showing high sen-
sitivity and specificity to a diagnosis of clinical
depression in low- and middle-income countries.23,24
Sociodemographic characteristics including age,
sex, and education (none/did not complete primary,
completed primary, secondary, tertiary) were col-
lected in the interviews. The measure for limiting
physical impairments was based on 12 items of com-
mon physical impairments,25 including arthritis/
rheumatism, eyesight problems, hearing difficulty or
deafness, persistent cough, breathlessness/asthma,
high blood pressure, heart trouble/angina, stomach
problems, intestine problems, faints/blackouts, skin
disorders, and paralysis/weakness or loss of one leg
or an arm. Impairments were rated as present if they
interfered with activities “a little” or “a lot,” as
opposed to “not at all.” The total number was then
categorized into three groups: none, one or two, or
three or more. Dementia was assessed using the 10/
66 dementia diagnosis adjusted for education, which
has been widely used in previous articles from the
10/66 Dementia Research Group, showing strong
psychometric properties. Further information on this
measure is available elsewhere.26Statistical Analysis
Before regression modeling, we reported the per-
centage of incident frailty by baseline depression sta-
tus excluding those participants with frailty, either
the modified Fried phenotype (N = 2,375) or multidi-
mensional frailty (N = 3,886) at baseline. Because mor-
tality was considered to be a competing outcome to
frailty in later life, a competing risk model was used
to investigate the associations between depression
and incidence of frailty. Subhazard ratio estimates
have similar interpretation to hazard ratios but also
account for a competing event (frailty-free mortality).
The proportional subhazard assumption was assessedAm J Geriatr Psychiatry 27:10, October 2019
Prina et al.generating time dependent covariates, by adding
interactions of the predictors and a function of sur-
vival time in the assessed model. Two types of frailty
outcomes, the modified Fried phenotype and multidi-
mensional frailty, were modeled separately. Adjusted
models included sociodemographic factors (age,
sex, and education), number of limiting physical
impairment, and dementia, which is related to depres-
sion and incident frailty. The unadjusted and adjusted
models were conducted for each country and pooled
estimates of all six countries were generated using a
fixed effect meta-analysis. Higgins I2, an indicator for
the level of heterogeneity,27 was used to assess varia-
tion in effect sizes across the six countries.
Inverse probability weighting was used to examine
the potential impact of participants lost to follow-up
(N = 1,369; 13.1%) on the results. Weights were gener-
ated using all variables in the fully adjusted model
and country and were applied to all competing risk
models. Because the weighted estimates were similar
to the unweighted ones, the results of complete case
analysis are reported here. A sensitivity analysis was
carried out to exclude people with dementia at base-
line and examine whether the associations were dif-
ferent in the participants without dementia. All
analyses were conducted using Stata version 15.1
(StataCorp LLC, College Station, TX).TABLE 1. Descriptive Information on the Study Population at Baseli
Cuba
Dominican
Republic
N 2,937 2,009 1
Age (Mean, SD) 75.1 (7.0) 75.3 (7.5) 74
Women (N, %) 1,909 (65.0) 1,325 (66.0) 1,18
Education (N, %)
None 75 (2.6) 392 (19.7) 12
Some 651 (22.2) 1,021 (51.3) 23
Primary 977 (33.4) 370 (18.6) 72
Secondary 728 (24.9) 135 (6.8) 51
Tertiary 498 (17.0) 73 (3.7) 32
Missing 8 18
Dementia (N, %) 322 (11.0) 242 (12.1) 16
Missing 0 0
Physical impairment (N, %)
None 1,286 (43.9) 599 (29.8) 88
1−2 1,353 (46.2) 945 (47.1) 78
3+ 292 (10.0) 464 (23.1) 26
Missing 6 1
Modified Fried phenotype frailty (N, %) 601 (20.5) 683 (34.0) 45
Multidimensional frailty (N, %) 976 (33.2) 942 (46.9) 52
Depression (N, %) 683 (23.3) 761 (37.9) 53
Notes: SD: standard deviation.
Am J Geriatr Psychiatry 27:10, October 2019RESULTS
Descriptive information on the baseline study pop-
ulation is provided in Table 1. Among the 12,844 par-
ticipants, the mean age was 74.7 (standard deviation:
7.2) years and 64.5% were women. Nearly 40% had
none or some education but did not complete pri-
mary school. The proportion of people with dementia
was 10%, and 17.8% had three or more limiting physi-
cal impairments. For frailty, 18.5% of participants had
modified Fried phenotype (two or more characteris-
tics), and 30.3% had multidimensional frailty. More
detailed information on the numbers of Fried frailty
characteristics is reported in Supplementary Table S1.
Approximately 12% (N = 1,546) of participants were
identified as having frailty using both definitions.
The proportion of people with depression at baseline
was 26.9% with a range between 16.5% in Puerto Rico
and 37.9% in Dominican Republic.
Table 2 reports the numbers and percentage of
frailty at follow-up by depression status. Participants
who had frailty at baseline were excluded. The per-
centages of both the modified Fried frailty phenotype
and multidimensional frailty were higher in partici-
pants with depression at baseline than those without
the condition across all countries.ne
Peru Venezuela Mexico Puerto Rico Total
,933 1,961 2,002 2,002 12,844
.8 (7.4) 72.5 (6.9) 74.3 (6.7) 76.3 (7.4) 74.7 (7.2)
3 (61.2) 1,249 (63.7) 1,267 (63.3) 1,347 (67.3) 8,280 (64.5)
1 (6.3) 155 (8.1) 554 (27.7) 72 (3.6) 1,369 (10.7)
1 (12.1) 444 (23.1) 863 (43.2) 389 (19.5) 3,599 (28.2)
7 (37.9) 964 (50.2) 351 (17.6) 415 (20.8) 3,804 (29.8)
7 (27.0) 266 (13.8) 124 (6.2) 713 (35.7) 2,483 (19.5)
1 (16.7) 93 (4.8) 108 (5.4) 410 (20.5) 1,503 (11.8)
16 39 2 3 86
6 (8.6) 142 (7.2) 179 (8.9) 233 (11.7) 1,284 (10.0)
0 0 0 9 9
7 (45.9) 748 (38.8) 835 (41.7) 708 (35.4) 5,063 (39.6)
0 (40.4) 693 (35.9) 824 (41.2) 865 (43.2) 5,460 (42.7)
4 (13.7) 488 (25.3) 343 (17.1) 429 (21.4) 2,280 (17.8)
2 32 0 0 41
1 (23.3) 220 (11.2) 183 (9.1) 237 (11.8) 2,375 (18.5)
4 (27.1) 405 (20.7) 592 (29.6) 447 (22.3) 3,886 (30.3)
7 (27.8) 574 (29.3) 574 (28.7) 330 (16.5) 3,459 (26.9)
1075
TABLE 2. Depression Status at Baseline and Frailty at Follow-Upa
Modified Fried Phenotype
Frailty (2−4 Characteristics)
at Follow-Up:
N (%)
Multidimensional
Frailty at Follow-Up:
N (%)
Depression
Status No Yes No Yes
Cuba No depression 1,202 (87.7) 184 (13.3) 859 (71.1) 350 (29.0)
Symptoms 231 (80.2) 57 (19.8) 182 (67.2) 89 (32.8)
Dominican Republic No depression 454 (76.7) 138 (23.3) 326 (64.7) 178 (35.3)
Symptoms 138 (60.5) 90 (39.5) 96 (52.5) 87 (47.5)
Peru No depression 681 (84.1) 129 (15.9) 645 (84.8) 116 (15.2)
Symptoms 166 (77.9) 47 (22.1) 174 (78.0) 49 (22.0)
Venezuela No depression 804 (94.5) 47 (5.5) 663 (85.0) 117 (15.0)
Symptoms 246 (86.9) 37 (13.1) 211 (83.7) 41 (16.3)
Mexico No depression 787 (79.5) 203 (20.5) 523 (65.0) 282 (35.0)
Symptoms 233 (65.6) 122 (34.4) 143 (55.2) 116 (44.8)
Puerto Rico No depression 821 (82.8) 171 (17.2) 624 (68.9) 282 (31.1)
Symptoms 87 (58.4) 62 (41.6) 98 (60.9) 63 (39.1)
Across centers No depression 4,749 (84.5) 872 (15.5) 3,640 (73.3) 1,325 (26.7)
Symptoms 1,101 (72.6) 415 (27.4) 904 (67.0) 445 (33.0)
Notes: aDepression symptomatology is defined as having either EURO-D or ICD-10 depression.
People From Six Latin American CountriesThe results of competing risk modeling are
reported in Table 3. Depression was associated with
an increased hazard of incident frailty. For the mod-
ified Fried phenotype defined by two or more char-
acteristics, the unadjusted pooled estimate was 1.87
(95% confidence interval [CI]: 1.66, 2.10; Z-
test = 10.56; p < 0.001), which was reduced to 1.59
(95% CI: 1.40, 1.80; Z-test = 7.29; p < 0.001) after tak-
ing into account sociodemographic factors, physical
impairment, and dementia. The association was
also found in the modified Fried phenotype defined
by three or four characteristics (1.71; 95% CI: 1.24,
2.38; Z-test = 3.24; p = 0.001). For multidimensional
frailty, the unadjusted effect size was 1.29 (95% CI:
1.16, 1.43; Z-test = 4.67; p < 0.001) and became 1.19
(95% CI: 1.06, 1.33; Z-test = 3.02; p = 0.002) after
adjustment. Variations in hazard ratios across coun-
tries were also smaller when using the multidimen-
sional frailty (I2 = 0.0) compared to the modified
Fried phenotype (I2 = 63.5). All countries apart from
Cuba showed a 20%−30% higher hazard of incident
multidimensional frailty in those who had depres-
sion at baseline.
The results of sensitivity analysis showed that the
associations between depression and frailty were
robust when excluding people with dementia at base-
line (Supplementary Table S1). The effect sizes were
generally similar to the main analysis.1076DISCUSSION
Main Findings
This study investigated the potential impact of
depression on incident frailty in older people from six
Latin American countries and considered both modi-
fied Fried phenotype and multidimensional frailty.
The results suggest that older people who had
depression were more likely to develop frailty com-
pared with those without depression. Depression, a
highly prevalent condition in later life, was associated
with a 60% increased hazard of modified Fried phe-
notype frailty and 20% for multidimensional frailty
after adjusting for sociodemographic factors, physical
impairments, and dementia and considering the com-
peting outcome of mortality. This means that up to
one-third of frailty could be attributed to depression
in later life.Strengths and Limitations
Based on a population-based cohort study, this
study included a large number of older people in six
Latin American countries. Complete information on
physical and mental health conditions were collected
through standardized and structured interviews. The
analysis included two types of frailty measures andAm J Geriatr Psychiatry 27:10, October 2019
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Prina et al.
Am J Geriatr Psychiatry 27:10, October 2019used competing risk modeling to account for high
mortality in later life.
This study had some potential limitations.
Although the 10/66 sample was selected to be as rep-
resentative as possible of the general population, it is
based on catchment areas that are not nationally rep-
resentative. This might affect generalizability of the
results but the strong association between depression
and frailty was clear across older people in different
settings. A modified version of Fried phenotype
frailty was used here19,20 and the results might not be
comparable to existing studies using the full Fried cri-
teria. However, lack of grip strength information
might not affect the results. Previous studies have
reported that the association between grip strength
and adverse health conditions was attenuated when
adjusting for other frailty indicators and confounding
factors.28,29 Although the multidimensional criteria
was used to incorporate a wide range of indicators
related to frailty, some domains such as cognition
and nutrition could be sensitive to cultural and envi-
ronmental factors. Because of limited statistical
power, the analysis did not test variation across coun-
tries, but 95% CIs largely overlapped. Some factors
such as biomarkers for inflammation and dopamine
could be mediators in the association between depres-
sion and frailty,8,11 but were not investigated in this
study owing to a lack of relevant measures in the
10/66 surveys.Interpretation of Results
This study suggests a negative impact of depres-
sion on incident frailty in later life and provides addi-
tional evidence from low- and middle-income
countries. The negative relationship corresponds to a
recent meta-analysis, which summarized eight cross-
sectional studies and four longitudinal studies mainly
based on older people living in high-income coun-
tries.8 Compared with the pooled estimates reported
in the meta-analysis, the effect sizes found in this
study were much smaller for both frailty definitions.
Although a negative relationship between depression
and frailty in later life has been consistently reported
in study populations from different countries, it is
noteworthy that the strength of associations could be
related to variations in study designs and measure-
ment methods.1077
People From Six Latin American CountriesThe effect sizes were found to be different when
using the modified Fried frailty phenotype and multi-
dimensional criteria. This may have been driven by
two explanations: 1) frailty measured using Fried cri-
teria tries to capture a unidimensional latent trait
summarized as a dichotomous syndrome. This defini-
tion has very strong theoretical and biological under-
pinnings, which may reflect an identifiable and
shared bioinflammatory pathway between depres-
sion and frailty,8,11 for example, C-reactive protein
and interleukin-6 have been shown to be elevated in
both people with frailty and people with depres-
sion;30,31 and 2) one of the criteria of Fried frailty
(exhaustion) is very common in people with depres-
sion.32 We therefore expected to see a stronger rela-
tionship between depression and this definition of
frailty, compared with multidimensional frailty.
The results from this study suggest that depression
in later life may increase the hazard of developing
frailty. Depressive symptoms can cause changes in
sleep, appetite, physical activity, reduction in help
seeking behavior, and adherence to medical treat-
ments.33−35 These psychological and behavior symp-
toms might lead to weakness, decreased energy, and
accelerate declines in physiological systems such as
immune system.11,36,37
IMPLICATIONS AND FUTURE RESEARCH
DIRECTIONS
Depression is a treatable condition and improving
treatments for this common mental disorder in later
life may be beneficial to reduction in disability and
mortality38 as well as frailty prevention. Underlying
mechanisms between depression and frailty need to
be further explored to inform potential interventions.
To clarify the causal relationship, longitudinal studies
need to have frequent follow-up and robust measures
for depression and frailty over a long time period.
Future research may also consider the cumulative
effect of depression through the life course. For exam-
ple, long-term depression has been related to brain
inflammation.39 Measurements for midlife depression1078may provide additional information to underpin
potential pathways and clarify the role of inflamma-
tion in these two conditions.CONCLUSIONS
Depression appears to play a key role in the devel-
opment of frailty in older adults living in Latin Amer-
ica. Underlying mechanisms between physical and
mental health in later life need to be further investi-
gated in future research.
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